ArticleHeliyon2024
Fractional gradient optimized explainable convolutional neural network for Alzheimer's disease diagnosis.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Use of explainable AI (xAI) in dementia detection and prognosis: a scoping review.BMC medical informatics and decision making · 2026Article
- Utilizing fractional-order operator to Alzheimer's disease dynamics.Scientific reports · 2026Article
- Convolutional neural networks in brain disease diagnosis: a unified review of Alzheimer's, Parkinson's, and brain tumor classification.Frontiers in neuroscience · 2026Review
- Artificial intelligence empowers gut microbiota research in neurodegenerative diseases molecular mechanisms and precision therapy.iScience · 2025Review
- Stability and chaos analysis of neurological disorder of complex network with fractional order comparative study.Scientific reports · 2025Article
- Explainable Artificial Intelligence in Neuroimaging of Alzheimer's Disease.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's is one of the brain syndromes that steadily affects the brain memory. The early stage of Alzheimer's disease (AD) is referred to as mild cognitive impairment (MCI), and the growth of Alzheimer's is not certain in patients with MCI. The premature detection of Alzheimer's is crucial for maintaining healthy brain function and avoiding memory loss. Different multi-neural network architectures have been proposed by researchers for efficient and accurate AD detection. The absence of improved feature extraction mechanisms and unexplored efficient optimizers in complex benchmark architectures lead to an inefficient and inaccurate AD classification. Moreover, the standard convolutional neural network (CNN)-based architectures for Alzheimer's diagnosis lack interpretability in their predictions. An interpretable, simplified, yet effective deep learning model is required for the accurate classification of AD. In this study, a generalized fractional order-based CNN classifier with explainable artificial intelligence (XAI) capabilities is proposed for accurate, efficient, and interpretable classification of AD diagnosis. The proposed study (a) classifies AD accurately by incorporating unexplored pooling technique with enhanced feature extraction mechanism, (b) provides fractional order-based optimization approach for adaptive learning and fast convergence speed, and (c) suggests an interpretable method for proving the transparency of the model. The proposed model outperforms complex benchmark architectures with regard to accuracy using standard ADNI dataset. The proposed fractional order-based CNN classifier achieves an improved accuracy of 99 % as compared to the state-of-the-art models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.